CXCR5+CD8 T cell persistence following ICB may generate a greater antibody repertoire based on their known B cell interactions that could be beneficial for tumor eradication or generate organ specific detriments and IMAEs (1, 79, 83). The gene discussed is CD8A; the disease is neoplasm.